An Indian pharmaceutical company is working to bring a significantly more affordable version of a popular weight loss medication to market, potentially offering substantial savings for patients.
Dr Reddy’s Laboratories revealed Tuesday that it intends to offer a generic alternative to Novo Nordisk’s widely-used weight loss treatment Wegovy, with pricing approximately 60% below the brand-name version, according to co-chairman and managing director GV Prasad speaking with Reuters.
The pharmaceutical manufacturer secured authorization from India’s drug regulatory authority last month to produce and distribute a generic equivalent of the diabetes medication Ozempic, another blockbuster drug from Novo Nordisk. The company indicated it is currently waiting for similar regulatory clearance for its proposed Wegovy alternative.
The development comes as demand for these types of medications continues to grow, with many patients seeking more affordable options for weight management and diabetes treatment.
